42 results on '"Huang, Wei-Han"'
Search Results
2. Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies
3. Recent advancements in hematopoietic stem cell transplantation in Taiwan
4. Effectiveness of Chinese herbal medicine as a complementary treatment for neutropenia prevention and immunity modulation during chemotherapy in patients with breast cancer: study protocol for a real-world pragmatic clinical trial (Preprint)
5. S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
6. Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor–mutated lung adenocarcinoma
7. Implementation of Noninvasive Preimplantation Genetic Testing for Aneuploidy with Spent Blastocyst Medium into Clinical and Laboratory Practice: The First Successful Experience in Taiwan
8. Prognostic Factors of Fournier's Gangrene in the Elderly: Experiences of a Medical Center in Southern Taiwan
9. Abnormal platelet immunophenotypes and percentage of giant platelets in myelodysplastic syndrome: A pilot study
10. Carfilzomib Use Among Patients with Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: Characteristics and Outcomes By Regimen from a Prospective, Real-World Study
11. Novel Bilayer Composite Membrane for Passive Direct Methanol Fuel Cells with Pure Methanol
12. Conversion of Escherichia coli into Mixotrophic CO 2 Assimilation with Malate and Hydrogen Based on Recombinant Expression of 2-Oxoglutarate:Ferredoxin Oxidoreductase Using Adaptive Laboratory Evolution.
13. Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community
14. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
15. Designing a Scoring System for Differential Diagnosis From Reactive Thrombocytosis and Essential Thrombocytosis
16. Capturing Pluripotency and Beyond
17. Bioinspired assembly of surface-roughened nanoplatelets
18. Multidimensional Flow Cytometry for Detection of Rare Populations in Hematological Malignancies
19. Acute Myeloid Leukemia Transformation from Myelofibrosis Upon Remission of an Orbital Myeloid Sarcoma – A Case Report
20. Robust fuzzy control for discrete perturbed time-delay affine Takagi-Sugeno fuzzy models
21. The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
22. Post-HSCT relapsed precursor B-cell ALL successfully salvaged by BiTE followed by consolidation CAR-T cell therapy: A report of two cases
23. Clinical Experiences with Recombinant Activated Factor VII for Managing Uncontrolled Hemorrhage in Non-Hemophilic Patients
24. Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
25. The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma.
26. Low-Energy Extracorporeal Shock Wave Therapy Ameliorates Kidney Function in Diabetic Nephropathy
27. Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor-mutated lung adenocarcinoma.
28. Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation.
29. Processing improvement and performance analysis of La 0.85 Sr 0.15 Ga 0.8 Mg 0.2 O 2.825 electrolyte-supported fuel cells
30. Corrigendum to “Prognostic Factors of Fournier's Gangrene in the Elderly: Experiences of a Medical Center in Southern Taiwan” [Int J Gerontol 10 (3) (2016) 151–155]
31. Factor B Inhibition with Oral Iptacopan Monotherapy Demonstrates Sustained Long-Term Efficacy and Safety in Anti-C5-Treated Patients (pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia: Final 48-Week Results from the Multicenter, Phase III APPLY-PNH Trial
32. Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli or Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
33. Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia colior Klebsiella pneumoniaand their emergence in the community
34. Carbapenem Therapy for Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia colior Klebsiella pneumoniae: Implications of Ertapenem Susceptibility
35. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia colior Klebsiella pneumoniae
36. Processing improvement and performance analysis of La0.85Sr0.15Ga0.8Mg0.2O2.825 electrolyte-supported fuel cells.
37. Effectiveness of Chinese Herbal Medicine as a Complementary Treatment for Neutropenia Prevention and Immunity Modulation During Chemotherapy in Patients With Breast Cancer: Protocol for a Real-World Pragmatic Clinical Trial.
38. BGLF4 kinase regulates the formation of the EBV cytoplasmic assembly compartment and the recruitment of cellular IQGAP1 for virion release.
39. Autologous stem cell transplantation in a patient with systemic sclerosis-associated interstitial lung disease in Taiwan.
40. The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma.
41. Post-HSCT relapsed precursor B-cell ALL successfully salvaged by BiTE followed by consolidation CAR-T cell therapy: A report of two cases.
42. Characteristics of Taiwanese patients of PNH in the international PNH registry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.